AGXT and neurodegenerative disease: Mutations in most members of the SPT complex, ceramide synthases, and DEGS1 lead to neurodegeneration (Hannun and Obeid, 2018; Dunn et al., 2019; Pan et al., 2023), identifying the de novo ceramide biosynthesis pathway as a hotspot for neurodegenerative disease mutations.